Related Experiment Video
Updated: May 18, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Regional cerebral blood flow differences in patients with mild cognitive impairment between those who did and did not
Kyung Won Park1, Hyun Jin Yoon, Do-Young Kang
1Department of Neurology, Dong-A University College of Medicine, Busan, Republic of Korea. neuropark@dau.ac.kr
Abstract:
Mild cognitive impairment (MCI) is a heterogeneous condition associated with increased risk of Alzheimer's disease (AD) and other dementias. This study aimed to identify areas of initial hypoperfusion in MCI conversion to AD using technetium (Tc-99m) hexamethylpropyleneamine oxime (TC-99m HMPAO) single photon emission computed tomography (SPECT) to compare baseline cerebral hypoperfusion in converted MCI and non-converted MCI patients and normal controls. Forty-nine MCI patients were recruited for brain magnetic resonance imaging (MRI), detailed neuropsychological testing, Tc-99m HMPAO SPECT, and 1- to 2-year periodic follow-up to monitor progression to dementia status. We processed SPECT images with Statistical Parametric Mapping 8 (SPM8) software and performed voxel-based statistical parametric mapping analysis. Thirty-nine of 49 MCI patients were included in our analysis. Nine patients were diagnosed with conversion to AD, on average 19.0±6.6 months after initial assessment. Compared with normal controls, converted MCI patients demonstrated perfusion deficits in both parahippocampal gyri and right precuneus, and non-converted MCI patients demonstrated hypoperfusion in the left parahippocampal gyrus. Compared with non-converted MCI patients, converted MCI patients demonstrated significant hypoperfusion in both cingulate gyri and right precuneus. Our study suggests that using brain SPECT to identify initial hypoperfusion in patients with MCI may be helpful for predicting MCI patients likely to develop AD.
Insights
Identifying early brain perfusion deficits in mild cognitive impairment (MCI) using technetium (Tc-99m) hexamethylpropyleneamine oxime (TC-99m HMPAO) single photon emission computed tomography (SPECT) can help predict Alzheimer's disease (AD) progression.
Area of Science:
- Neuroimaging
- Neurology
- Geriatrics
Background:
- Mild cognitive impairment (MCI) is a precursor to Alzheimer's disease (AD) and other dementias, characterized by heterogeneity.
- Early detection of neurodegenerative changes in MCI is crucial for timely intervention and disease management.
Purpose of the Study:
- To identify specific areas of initial cerebral hypoperfusion in MCI patients who convert to AD.
- To compare baseline perfusion deficits between MCI converters, non-converters, and healthy controls using SPECT imaging.
Main Methods:
- Recruited 49 MCI patients for brain MRI, neuropsychological testing, and Tc-99m HMPAO SPECT scans.
- Utilized Statistical Parametric Mapping 8 (SPM8) software for voxel-based analysis of SPECT images.
- Monitored patients for 1-2 years to determine conversion to dementia status.
Main Results:
- Converted MCI patients showed hypoperfusion in the parahippocampal gyri and right precuneus compared to controls.
- Non-converted MCI patients exhibited hypoperfusion in the left parahippocampal gyrus.
- Converted MCI patients had significant hypoperfusion in the cingulate gyri and right precuneus compared to non-converters.
Conclusions:
- Brain SPECT imaging can reveal early hypoperfusion patterns indicative of AD progression in MCI patients.
- Identifying these perfusion deficits may aid in predicting which MCI individuals are at higher risk for developing AD.
More Related Videos
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
08:43Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
Related Concept Videos
Dementia l: Introduction
Alzheimer Disease l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology